Overview

Memantine-enhanced Buprenorphine Treatment for Opioid-dependent Young Adults

Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the effect of memantine and buprenorphine on opioid abusing behavior, to determine the effect of memantine and buprenorphine on early relapse and to evaluate the tolerability of memantine co-administrated with buprenorphine. The study seeks to determine if combined treatment of memantine and buprenorphine may provide shorter-term treatment for opioid dependence.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
University of Massachusetts, Worcester
Collaborator:
National Institute on Drug Abuse (NIDA)
Treatments:
Buprenorphine
Memantine